Physician profile
Jennifer E Lee
NPI 1033502869
$10,330.33
in general payments reported to CMS, 2019-2025
28 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.77 · 2020: $3,222 · 2021: $3,387 · 2022: $361 · 2023: $432 · 2024: $2,730 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $800.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,594.90 | 2020-2024 | |
| Abbvie INC. | $606.04 | 2020-2023 | |
| Pfizer INC. | $125.27 | 2020-2024 | |
| Millicent US INC | $101.72 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $83.63 | 2021-2023 | Thinprep 2000 Processor, Aptima |
| Avion Pharmaceuticals | $71.33 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $70.09 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $69.01 | 2022-2023 | |
| Exeltis, USA INC. | $62.51 | 2021-2023 | Solosec |
| Myriad Genetic Laboratories, INC. | $52.88 | 2023 | Myrisk |
| Kowa Pharmaceuticals America, INC. | $52.69 | 2023 | Seglentis |
| Aspira Women'S Health INC | $47.80 | 2022-2023 | Ova1 |
| Daiichi Sankyo INC. | $40.30 | 2020-2021 | |
| Astellas Pharma US INC | $34.89 | 2025 | Veozah |
| Agile Therapeutics, INC. | $33.99 | 2022-2024 | Twirla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $33.81 | 2020-2022 | |
| Shield Therapeutics INC | $30.38 | 2023 | Accrufer |
| Axonics, INC. | $25.04 | 2021 | |
| Amag Pharmaceuticals, INC. | $23.85 | 2019 | |
| Allergan, INC. | $23.60 | 2019 | |
| Cook Medical LLC | $23.34 | 2023 | Cook |
| Evofem Biosciences, INC. | $22.30 | 2022 | |
| Mimedx Group, INC. | $21.48 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.16 | 2020 | |
| Scynexis, INC. | $16.67 | 2022 | |
| Organon LLC | $16.21 | 2021 | |
| Exact Sciences Corporation | $13.12 | 2023 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.